Skip to main content
رجوع
RPHCF logo

Rohto Pharmaceutical Co.,Ltd.

جودة البيانات: 100%
RPHCF
OTC Consumer Defensive Household & Personal Products
KWD 15.20
KWD 0.00 (0.00%)
القيمة السوقية: 3.43B
نطاق اليوم
KWD 15.20 KWD 15.20
نطاق 52 أسبوعًا
KWD 14.34 KWD 20.09
حجم التداول
150
متوسط 50 يوم / 200 يوم
KWD 15.96 / KWD 15.28
الإغلاق السابق
KWD 15.20

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Consumer Defensive (329 نظير)

المقياس السهم وسيط القطاع
P/E 0.1 10.5
P/B 0.0 1.2
ROE % 12.3 12.3
Net Margin % 10.1 5.3
Rev Growth 5Y % 14.3 5.5
D/E 0.2 0.6

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 177.729
KWD 169.938 – KWD 183.046
410 B 1
FY2029 KWD 167.625
KWD 160.278 – KWD 172.640
390 B 1
FY2028 KWD 156.133
KWD 149.289 – KWD 160.804
370 B 1

النقاط الرئيسية

Revenue grew 14.26% annually over 5 years — strong growth
ROE of 12.25% — decent returns on equity
Debt/Equity of 0.19 — conservative balance sheet
Generating 26.36B in free cash flow
P/E of 0.11 — trading at a low valuation
Cash machine — converts 85.00% of earnings into free cash flow

النمو

Revenue Growth (5Y)
14.26%
Revenue (1Y)13.95%
Earnings (1Y)0.23%
FCF Growth (3Y)1190.78%

الجودة

Return on Equity
12.25%
ROIC9.41%
Net Margin10.05%
Op. Margin12.62%

الأمان

Debt / Equity
0.19
Current Ratio2.30
Interest Coverage41.03

التقييم

P/E Ratio
0.11
P/B Ratio0.01
EV/EBITDA-0.60
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 13.95% Revenue Growth (3Y) 13.72%
Earnings Growth (1Y) 0.23% Earnings Growth (3Y) 8.42%
Revenue Growth (5Y) 14.26% Earnings Growth (5Y) 16.65%
Profitability
Revenue (TTM) 308.63B Net Income (TTM) 31.01B
ROE 12.25% ROA 7.35%
Gross Margin 56.68% Operating Margin 12.62%
Net Margin 10.05% Free Cash Flow (TTM) 26.36B
ROIC 9.41% FCF Growth (3Y) 1190.78%
Safety
Debt / Equity 0.19 Current Ratio 2.30
Interest Coverage 41.03 Dividend Yield 0.01%
Valuation
P/E Ratio 0.11 P/B Ratio 0.01
P/S Ratio 0.01 PEG Ratio 58.85
EV/EBITDA -0.60 Dividend Yield 0.01%
Market Cap 3.43B Enterprise Value -23.50B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 308.63B 270.84B 238.66B 199.65B 181.05B
Net Income 31.01B 30.94B 26.38B 21.13B 16.74B
EPS (Diluted) 135.44 135.21 115.29 92.34 73.18
Gross Profit 174.94B 157.29B 1.02B 937.32M 949.85M
Operating Income 38.94B 40.05B 33.96B 29.02B 22.99B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 421.88B 346.18B 2.33B 2.26B 2.05B
Total Liabilities 150.44B 99.14B 712.02M 746.57M 629.28M
Shareholders' Equity 260.09B 246.32B 1.58B 1.47B 1.41B
Total Debt 50.22B 10.49B 102.46M 21.38B 8.10B
Cash & Equivalents 77.16B 89.21B 584.78M 582.48M 472.90M
Current Assets 217.88B 214.76B 1.43B 1.35B 1.20B
Current Liabilities 94.61B 87.09B 603.38M 587.27M 511.05M

درجات الاستراتيجيات

This stock passed the criteria for 4 strategies

Score = fit strength (0–100)
Rank = position among all matches
#414 of 1052
50
#158 of 825
59
#493 of 618
16

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026
دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
دخل Defensive Investing (Benjamin Graham)
Mar 24, 2026